Lipid Mediators in Colonic Biopsies as Biomarkers of Disease Activity of Inflammatory Bowel Diseases

NACompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Inflammatory Bowel DiseasesColitis, UlcerativeCrohn Disease
Interventions
OTHER

Colonic Biopsy

"Colonoscopy or coloscopy can provide a visual diagnosis and grants the opportunity for biopsy or removal of suspected colorectal cancer lesions.~The endoscope is then passed through the anus up the rectum, the colon, and ultimately the terminal ileum. The endoscope has a movable tip and multiple channels for instrumentation, air, suction and light. Biopsies are frequently taken for histology, needed for cancer or IBD diagnosis.~Extra-biopsies for research purpose will only be performed if the clinician decides that they are necessary for the clinical diagnosis or for the disease follow-up.~For this protocol, collecting these extra biopsies should last under 5 minutes and should not extend the procedure by more than this time."

Trial Locations (1)

31059

University Hospital Toulouse, Toulouse

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

University Hospital, Toulouse

OTHER

NCT01990716 - Lipid Mediators in Colonic Biopsies as Biomarkers of Disease Activity of Inflammatory Bowel Diseases | Biotech Hunter | Biotech Hunter